Citations

Showing 10 of 108119 citations.

Thrombectomy for a Patient with Concomitant Acute Cervical Internal Carotid and Middle Cerebral Artery Occlusion: Video Case
Tian, Fucheng, Abi-Aad, Karl R., Krishna, Chandan , Bendok, Bernard R.

Mayo Clinic

Neurosurgery | March 12, 2019 | Volume: 85 | Issue: suppl_1 | Pages: S74-S75

10.1093/neuros/nyz084 | PMID 31197341 Get It

Abstract We present the case of a 62-yr-old female who presented with ground-level fall and new onset of left-sided weakness of 30 min duration. CT angiogram revealed right ICA pseudo-occlusion and thrombus filling the right proximal M1 segment of the right MCA. On detailed neurological exam patient was noted to have NIHSS of 25. Patient was started on IV TPA infusion and was taken to interventional angiography suite after an informed consent was obtained. Diagnostic angiography was performed which demonstrated critical stenosis of the right proximal internal carotid artery. Right carotid artery stenting and balloon angioplasty of the carotid stent with distal embolic protection device was performed. Post carotid stent angiogram once again confirmed proximal right M1 pseudo-occlusion in the right MCA distribution. The clot was removed using a stent retriever, thus achieving complete recanalization (TICI 3) of the right cerebral hemisphere. The patient returned to baseline neurological status and a 1 mo follow-up diagnostic angiogram revealed patent carotid stent. Following the case presentation, we present the nuances of acute ischemic stroke management of large vessel occlusion with an emphasis on technical nuances, recent published guidelines 1 and the literature. 2-8
Intraoperative High Impedance Levels During Placement of Deep Brain Stimulating Electrode
Lyons, Mark , Neal, Matthew T. , Patel, Naresh P. , Lyons, Mark K, Patel, Naresh P

Mayo Clinic

Operative Neurosurgery | March 12, 2019 | Volume: 17 | Issue: 6 | Pages: E264-E266

10.1093/ons/opz035 | PMID 30860268 Get It

Abstract BACKGROUND AND IMPORTANCE Deep brain stimulation (DBS) is a well-established treatment for medically refractory Parkinson's disease (PD), essential tremor (ET), and dystonia. The field of DBS is expanding and techniques are under investigation for the treatment of several neurological disorders. A critical component of the success of these procedures depends significantly on the reliability and durability of devices implanted. Immediate feedback during surgery often gives the surgeon and patient a sense of confidence of long term success. When impedances are found to be elevated during the implantation of the DBS leads, appropriate trouble shooting measures are critical. CLINICAL PRESENTATION We present a 73-yr-old male undergoing awake subthalamic DBS with microelectrode recordings for severe PD. Once the optimal trajectory and depth were ascertained, the permanent DBS electrode was placed. High impedances were recorded. Troubleshooting procedures were performed and were all negative as to the cause of the values. Correct impedance levels of the DBS electrode was confirmed with extracranial testing, but continued high values were found again with intracranial positioning of the electrode. A postoperative computerized tomography (CT) scan confirmed intracranial air surrounding all of the contacts. The patient went on to outpatient programming with excellent clinical results. CONCLUSION The presence of pneumocephalus surrounding the DBS lead contacts at the target nucleus may have accounted for the intraoperative impedance findings. When all troubleshooting checks have not identified an explanation for the high impedances, intraoperative imaging may demonstrate pneumocephalus around the lead contacts, which should resolve and impedances return to normal values.
Novel Endovascular Neck Reconstruction and Coiling Technique for the Treatment of a Large Wide-Necked Basilar Apex Aneurysm Through a Radial Artery Approach: 2-Dimensional Operative Video
Sorenson, Thomas J. , Castilla, Leonardo Rangel, Rangel Castilla, Leonardo, Lanzino, Giuseppe

Mayo Clinic

Operative Neurosurgery | March 12, 2019 | Volume: 17 | Issue: 4 | Pages: E157-E157

10.1093/ons/opz025 | PMID 30860267 Get It

Abstract Herein, we demonstrate a case of a large, wide-necked, basilar apex aneurysm (BAA) that was treated with neck reconstruction-assisted coil embolization using the PulseRider device (PulsarVascular, Los Gatos, California), a novel neck-reconstruction device. A 68-yr-old man was found to have large BAA during work-up for sinusitis. Computed tomography angiogram revealed an 11 × 10-mm BAA. Patient has history of coronary artery disease, atrial fibrillation (currently taking Warfarin), recent left hip replacement and right femoral bypass. Treatment of the aneurysm was advised due to its location and size. Microsurgical clip reconstruction was high risk for general anesthesia due to his medical comorbidities and anticoagulation. Wide-necked bifurcation aneurysms are challenging to treat with traditional balloon- or stent-assisted techniques. To mitigate these challenges, novel neck-reconstruction devices have been developed. The Pulsar is one of these neck-reconstruction devices that removes the need to selectively catheterize branch arteries; it is available in a “Y” and “T” configuration. Under conscious sedation and through a radial artery approach, the patient underwent endovascular reconstruction of BAA with Pulsar device and coils. A 6-Fr guide catheter, a 0.021" microcatheter for the Pulsar device and a 0.017" microcatheter for coil delivering were used. A 3 × 8.6 mm Pulsar device was selected based on aneurysm neck and basilar artery measurements. Complete embolization (Raymond-Roy 1 obliteration) of the aneurysm was successfully achieved with no complications. The patient remained neurologically intact and was discharged on postoperative day 1. Parts of this video were published in Intracranial Aneurysms (1st Edition), Ringer (Ed), online companion to chapter 33B, Copyright Elsevier (2018).
Factors Affecting Return to Play After Primary Achilles Tendon Tear: A Cohort of NFL Players
Yang, Jae-Won, Hodax, Jonathan D., Krill, Michael K. , Lemme, Nicholas J. , Durand, Wesley M. , Hoffman, Joshua, Hewett, Timothy E. , Machan, Jason T. , Owens, Brett D.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | March 12, 2019 | Volume: 7 | Issue: 3 | Pages: No page available

10.1177/2325967119830139 | PMID 30886876 Get It

Background: Achilles tendon tears are potentially career-ending injuries for professional athletes. For players in the National Football League (NFL), return requires not only surgery and extensive rehabilitation but also the ability to compete in a market with limited positions that annually introduces new recruits. Purpose/Hypothesis: We authors sought to evaluate factors related to return to play (RTP) and changes in performance following a primary Achilles tear. Our hypothesis was that “skilled” position players and those drafted in later rounds would return at a lower rate as compared with “unskilled” position players and higher draft-round players. Study Design: Case-control study; Level of evidence, 3. Methods: From a previously established database, 80 NFL players were identified as having primary Achilles tendon tears between the 2009 and 2014 seasons. RTP was defined as playing in a regular season or postseason game following injury. Probability of RTP was modeled as a function of time after injury in Kaplan-Meier analysis with demographic variables assessed via generalized linear models. Twelve players (15%) experienced a subsequent Achilles tendon tear during or after the study period and were included in the overall RTP rate but were excluded from performance analyses owing to the confounding effects of an ipsilateral retear or contralateral tear. Results: The overall RTP rate was 61.3%. Age, number of prior seasons, position type, or draft round status did not significantly affect RTP when evaluated with Kaplan-Meier analysis. In the season before their injury, players who did RTP played in a significantly greater number of regular season games (13.7) compared with players who did not RTP (8.71) ( P = .011). Players who did not RTP exhibited a significant decrease in performance in the season preceding injury (12.7 regular season games played 2 seasons preinjury vs 8.71 regular season games played 1 season prior preinjury;, P = .019). Players who returned did not display a significant change in the number of games played or started in seasons following injury when >1 season after return was evaluated. Conclusion: Rate of RTP following primary Achilles tendon tears may be lower than previously published. However, for those able to return, performance only in the season immediately following injury appears to be affected; players return to preinjury levels if given the opportunity to play >1 season after injury.
The Spatial and Temporal Variability of the Indoor Environmental Quality during Three Simulated Office Studies at a Living Lab
Clements, Nicholas , Zhang, Rongpeng , Jamrozik, Anja , Campanella, Carolina , Bauer, Brent A.

Mayo Clinic

Buildings | March 12, 2019 | Volume: 9 | Issue: 3 | Pages: 62

10.3390/buildings9030062 Get It

The living lab approach to building science research provides the ability to accurately monitor occupants and their environment and use the resulting data to evaluate the impact that various components of the built environment have on human comfort, health, and well-being. A hypothesized benefit of the living lab approach is the ability to simulate the real indoor environment in an experimentally controlled setting over relatively long periods of time, overcoming a significant hurdle encountered in many chamber-type experimental designs that rarely reflect typical indoor environments. Here, we present indoor environmental quality measurements from a network of sensors as well as building system design and operational data demonstrating the ability of a living lab to realistically simulate a wide range of environmental conditions in an office setting by varying air temperature, lighting, façade control, and sound masking in a series of three human subject experiments. The temporal variability of thermal and lighting conditions was assessed on an hourly basis and demonstrated the significant impact of façade design and control on desk-level measurements of both factors. Additional factors, such as desk layout and building system design (e.g., luminaires, speaker system), also contributed significantly to spatial variability in air temperature, lighting, and sound masking exposures, and this variability was reduced in latter experiments by optimizing desk layout and building system design. While ecologically valid experimental conditions are possible with a living lab, a compromise between realism and consistency in participant experience must often be found by, for example, using an atypical desk layout to reduce spatial variability in natural light exposure. Based on the experiences from these three studies, experimental design and environmental monitoring considerations for future office-based living lab experiments are explored.
Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies
Sonbol, Mohamad Bassam , Ahn, Daniel H. , Bekaii‐Saab, Tanios , Sonbol, Mohamad B , Bekaii-Saab, Tanios S

Mayo Clinic

Biomedicines | March 12, 2019 | Volume: 7 | Issue: 1 | Pages: 17

10.3390/biomedicines7010017 | PMID 30857342 Get It

Cancer stem cells (CSCs) are thought to be a distinct population of cells within a tumor mass that are capable of asymmetric division and known to have chemoresistant characteristics. The description and identification of CSC models in cancer growth and recurrence has inspired the design of novel treatment strategies to overcome treatment resistance by targeting both CSCs and non-CSC tumor cells. Several cellular signaling pathways have been described as playing a role in the induction and maintenance of stemness in CSCs, such as the Wnt/β-catenin, Notch, STAT3, and Hedgehog pathways. In this review, we aim to review some of the ongoing CSC therapeutic targeting strategies in gastrointestinal malignancies.
Comparison of the NCCN‐IPI, the IPI and PIT scores as prognostic tools in peripheral T‐cell lymphomas
Ellin, Fredrik , Maurer, Matthew J. , Srour, Line, Farooq, Umar , Smedby, Karin E. , Ansell, Stephen M. , Slack, Graham W. , Relander, Thomas, Cerhan, James R , Savage, Kerry J , Maurer, Matthew , Farooq, Umar , Jerkeman, Mats , Connors, Joseph M. , Bennani, N. Nora , Cerhan, James R. , Feldman, Andrew L. , Savage, Kerry J.

Mayo Clinic

British Journal of Haematology | March 12, 2019 | Volume: 186 | Issue: 3 | Pages: No page available

10.1111/bjh.15859 | PMID 30859549 Get It

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Shroff, Rachna T. , Kennedy, Erin B. , Bekaii‐Saab, Tanios , Crane, Christopher H. , Feng, Mary, Katz, Matthew H. G. , Primrose, John , Bekaii-Saab, Tanios S , Katz, Matthew H G , Bachini, Melinda , Edeline, Julien , El-Khoueiry, Anthony B. , Soares, Heloisa P. , Valle, Juan W. , Maithel, Shishir K

Mayo Clinic

Journal of Clinical Oncology | March 11, 2019 | Volume: 37 | Issue: 12 | Pages: 1015-1027

10.1200/jco.18.02178 | PMID 30856044 Get It

PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the literature on adjuvant therapy for resected biliary tract cancer and provide recommended care options for this patient population. RESULTS Three phase III randomized controlled trials, one phase II trial, and 16 retrospective studies met the inclusion criteria. RECOMMENDATIONS Based on evidence from a phase III randomized controlled trial, patients with resected biliary tract cancer should be offered adjuvant capecitabine chemotherapy for a duration of 6 months. The dosing used in this trial is described in the qualifying statements, while it should be noted that the dose of capecitabine may also be determined by institutional and regional practices. Patients with extrahepatic cholangiocarcinoma or gallbladder cancer and a microscopically positive surgical resection margin (R1 resection) may be offered chemoradiation therapy. A shared decision-making approach is recommended, considering the risk of harm and potential for benefit associated with radiation therapy for patients with extrahepatic cholangiocarcinoma or gallbladder cancer. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines .
Subependymoma involving multiple spinal cord levels: A clinicopathological case series with chromosomal microarray analysis
Mikula, Anthony L. , Paolini, Michael A., Sukov, William R. , Raghunathan, Aditya , Raghunathan, Aditya , Clarke, Michelle J.

Mayo Clinic

Neuropathology | March 11, 2019 | Volume: 39 | Issue: 2 | Pages: 97-105

10.1111/neup.12543 | PMID 30856298 Get It

Subependymomas of the spinal cord are rare, do not often involve multiple levels, and very rarely recur. Here, we present a series of spinal cord subependymomas with a detailed description of the clinical, radiological and pathological features, and characterization by chromosomal microarray analysis. Briefly, the four patients included two men and two women, between the ages of 22 and 48 years. The most common presenting symptoms were neck and arm pain with upper extremity weakness. By imaging, the tumors were found to involve multiple spinal levels, including cervical/ cervico‐thoracic (three patients) and thoracic (one patient), were all eccentric, and had minimal to no post‐contrast enhancement. Two patients underwent gross total resection, one had a sub‐total resection, and one underwent biopsy alone with a decompressive laminectomy. Follow up ranged from 6 months to 22 years. One patient (case 4) had recurrence 15 years following gross total resection and chromosomal microarray analysis revealed deletions on the long arm of chromosome 6. Our limited series suggests that spinal cord subependymomas can rarely recur, even following gross total resection, suggesting a possible role for long‐term surveillance for these rare tumors.
Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy
Wilbanks, Brandon , Smestad, John , Heider, Robin M., Warrington, Arthur E. , Rodriguez, Moses , Rodriguez, Moses , III, Louis James Maher , Smestad, John , Wilbanks, Brandon A

Mayo Clinic

Nucleic Acid Therapeutics | March 11, 2019 | Volume: 29 | Issue: 3 | Pages: 126-135

10.1089/nat.2018.0776 | PMID 30855209 Get It

We previously reported the in vitro selection and characterization of a DNA aptamer capable of stimulating remyelination in a mouse model of multiple sclerosis. This aptamer was selected for its ability to bind to suspensions of crude murine myelin in vitro . Our initial studies in vitro and in vivo involved a 40-nucleotide derivative (LJM-3064) of the original 100-nucleotide aptamer. LJM-3064 retained robust myelin-binding properties. Structural characterization of LJM-3064 revealed that the guanosine-rich 5′ half of the sequence forms different G-quadruplex-type structures that are variably stable in the presence of physiologically relevant ions. We hypothesized that this structured domain is sufficient for myelin binding. In this study, we confirm that a 20-nucleotide DNA, corresponding to the 5′ half of LJM-3064, retains myelin-binding properties. We then optimize this minimal myelin-binding aptamer via systematic evolution of ligands by exponential enrichment after sparse rerandomization. We report a sequence variant (LJM-5708) of the 20-nucleotide myelin-binding aptamer with enhanced myelin-binding properties and the ability to bind cultured human oligodendroglioma cells in vitro , providing the first evidence of cross-species reactivity of this myelin-binding aptamer. As our formulation of DNA aptamers for in vivo remyelination therapy involves conjugation to streptavidin, we verified that the myelin-binding properties of LJM-5708 were retained in conjugates to avidin, streptavidin, and neutravidin. DNA aptamer LJM-5708 is a lead for further preclinical development of remyelinating aptamer technologies.